Gainers
- Revelation Biosciences (NASDAQ:REVB) shares rose 63.4% to $0.41 during Tuesday's regular session. The current volume of 63.1 million shares is 2413.6% of Revelation Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $9.6 million.
- Taysha Gene Therapies (NASDAQ:TSHA) stock rose 62.31% to $2.45. The current volume of 60.2 million shares is 53508.4% of Taysha Gene Therapies's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $100.7 million.
- Medpace Hldgs (NASDAQ:MEDP) shares rose 37.16% to $217.6. Medpace Hldgs's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 656.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 billion. As per the press release, Q3 earnings came out yesterday.
- Revelation Biosciences (NASDAQ:REVBU) shares moved upwards by 34.37% to $0.43. As of 13:30 EST, Revelation Biosciences's stock is trading at a volume of 524.8K, which is 382.7% of its average full-day volume over the last 100 days.
- Nutex Health (NASDAQ:NUTX) stock rose 31.21% to $0.81. Trading volume for Nutex Health's stock is 8.6 million as of 13:30 EST. This is 302.5% of its average full-day volume over the last 100 days. The company's market cap stands at $527.4 million.
- Renalytix (NASDAQ:RNLX) stock increased by 28.3% to $1.36. Renalytix's stock is trading at a volume of 290.3K shares as of 13:30 EST. This is 300.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $50.9 million.
